Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from BioGaia AB submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Sweden, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific...

詳細記述

保存先:
書誌詳細
出版年:EFSA J
主要な著者: Turck, Dominique, Castenmiller, Jacqueline, De Henauw, Stefaan, Ildico Hirsch‐Ernst, Karen, Kearney, John, Knutsen, Helle Katrine, Maciuk, Alexandre, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Pelaez, Carmen, Pentieva, Kristina, Thies, Frank, Tsabouri, Sophia, Vinceti, Marco, Bresson, Jean‐Louis, Sanz, Yolanda, Siani, Alfonso
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2020
主題:
Scientific Opinion
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7447865/
https://ncbi.nlm.nih.gov/pubmed/32874242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2020.6004
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料